Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion
about
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementFault detection and safety in closed-loop artificial pancreas systemsA Review of Safety and Design Requirements of the Artificial Pancreas.Processing Diabetes Mellitus Composite Events in MAGPIE.Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial.Clinical review: insulin pump-associated adverse events in adults and children.Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wearEvaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.Insulin Infusion Set Use: European Perspectives and Recommendations.Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes TechnoMultiple Daily Injections OR Insulin Pump Therapy: Choosing the Best Option for Your Patient-An Evidence-based Approach.Moving toward the ideal insulin for insulin pumps.Controlled release of biologics for the treatment of type 2 diabetes.Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future Directions.A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach.Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas.Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release.Controlled release of cytokines using silk-biomaterials for macrophage polarization.Skin Oil Staining to Avoid Infusion Set Cannula Crimping: A Personal Observation.We Need More Research and Better Designs for Insulin Infusion SetsPatch pump versus conventional pump: postprandial glycemic excursions and the influence of wear time.Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine.A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas.Systematic in vivo evaluation of the time-dependent inflammatory response to steel and Teflon insulin infusion catheters.Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life.Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - An illustration with firsthand examples.Analysis of "Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life".Skin-Related Complications Among Adolescents With Type 1 Diabetes Using Insulin Pump Therapy
P2860
Q26769878-7C1718B4-65D0-4419-B836-E1882A1F57D3Q26859052-5A11B5CC-89B2-4848-B453-A85725419A28Q28066687-B6F8E134-5AD8-4B1E-8ABD-5EB3F5C3221BQ33446002-3C13E938-C300-42D1-B1A9-E80305C87780Q33454851-6A53A64D-054D-4DB0-92C8-7FCB104EEF35Q35669227-A9EE4CF7-FFCC-4240-AFEC-2782963CF336Q35929406-82C9A52E-2BD1-411B-93F2-EC8F8D0240E6Q36340397-F603558C-5139-4DFC-B44B-A9143A5785FEQ36683272-DC6D6F65-E3E5-4B2B-A89D-0514A58C0ADBQ37062173-1CEE5632-5538-4AFB-8925-06B4195BEF4FQ37275651-1E814DCD-3964-43AF-9F6C-4F01FBA1A5B0Q37292156-9D5D2F4B-758B-4D9C-920E-C700DB44B581Q38205861-732990E2-FCBD-487E-A336-2861A0B45EB0Q38373217-BCB58F88-7D62-49FC-823C-3B310D53DD3CQ38382412-B77C6ACF-25AE-45AC-B115-E836C20B2961Q38580509-CBCC7773-3783-4F0A-8622-C428372DFA59Q38631154-097FE3B4-C51E-4C8A-B259-3A250D4D7BC6Q38665753-71E1FD77-767E-4AA1-8968-25AB27E00FE0Q38884258-4F66BB11-C4FA-446B-BF34-C1423CA1CEB7Q39306224-C6AF9B49-C522-49DF-B7EB-ABF8861EB0C8Q41458753-FA582673-CECA-4851-8ED2-222E70C02628Q41680762-1BCFF063-E50E-4B39-B317-28645BEFB03EQ42176598-E10C3CF2-0C7E-40B2-A4AE-5FF3BCB5F768Q42392244-37AD635F-8F0A-4C53-B812-93DF0397E05CQ42724019-15DCCDB3-10B3-4E49-8366-4D9FAD5AF24DQ43094790-001F67BA-3538-41E6-AF55-0441A8F975A7Q45834106-C21ACCE6-587F-4764-87AC-3260A7105A44Q47164889-5AD3EC07-36C0-45E5-BD12-CFED5D8E8BC9Q47553121-0C8EAFCF-81D5-4EF2-90C8-7FBF06C5C502Q49951304-D94804C7-EBB2-4FC7-84A3-CCFE34497BD0Q51169744-F7ED33E3-8898-401C-BD6F-BB3F016A819FQ52561274-78F36834-FE41-4241-B760-41413498F52EQ53518052-24FDE966-0153-4836-B0BD-F9697992B4D4Q58763315-CDFE529C-6C1D-4B09-91A2-04E58DF23AC2
P2860
Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion
@en
type
label
Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion
@en
prefLabel
Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion
@en
P2860
P1476
Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion
@en
P2093
Lars Krinelke
P2860
P304
P356
10.1177/193229681200600429
P577
2012-07-01T00:00:00Z